- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT04868669
Improving Maternal Nutrition in Matlab (IMNiM)
In-home, Intensive Nutrition Counseling to Improve Gestational Weight Gain in Rural Bangladesh: A Cluster-Randomized Controlled Trial
Background: Maternal undernutrition and inadequate gestational weight gain (GWG) are prevalent in rural communities of low- and middle-income countries (LMICs). In Matlab, Bangladesh, 54% of the women fail to gain adequate weight (>4 kg) in the third trimester. Risks associated with inadequate GWG include giving birth to a small-for-gestational age (SGA) infant, low birth weight (LBW) infant, preterm birth (PTB), etc. Few contemporary studies examined the efficacy of nutrition counseling on GWG improvement in LMICs.
Objectives: The primary objective of this study is to assess whether in-home, intensive nutrition counseling during pregnancy, compared to standard antenatal care, could improve GWG among pregnant women in rural Bangladesh.
Methods: This prospective, two-arm, parallel group, equal allocation, open-label, community-based, cluster-randomized controlled trial will be conducted in the icddr,b service area of Matlab, a rural subdistrict of Bangladesh. Clusters will be randomly allocated 1:1 to the intervention arm in which pregnant women will receive monthly in-home, intensive nutrition counseling or the control arm in which pregnant women will receive standard antenatal care as offered by icddr,b and Govt. facilities. Fixed Site Clinics (FSCs) located at the homes of the community health research workers (CHRWs) will act as clusters. Of the 33 FSCs serving rural areas in the icddr,b service area, 20 will be selected randomly and listed. These 20 clinics will then be randomly allocated 1:1 to either an intervention or control group using a computer-generated random allocation sequence. To fulfil the required sample size, each selected CHRW will enroll 16 consecutive pregnancies. Required sample size is 16 women per cluster i.e. 160 women per arm. Eligible participants will be enrolled upon obtaining their consent by 13 and 6/7 weeks of gestation (first trimester) and followed up to 6 weeks postpartum. Trained health workers will visit the homes of the women in the intervention arm once a month and provide nutrition counseling to the women and her influential family members such as mothers, mothers-in-law and husbands. Both intention-to-treat and per-protocol analyses will be performed.
Outcome measures/variables: Proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to the US Institute of Medicine (IOM) 2009 guidelines is the primary outcome variable.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Chandpur, Bangladesz
- International Centre for Diarrhoeal Disease Research, Bangladesh
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Pregnant women permanently residing in the icddr,b service area of Matlab fulfilling the following criteria:
Inclusion Criteria:
- aged 18-39 years
- in the first trimester of pregnancy (before 14 weeks of gestation)
- BMI 16-24.99 kg/m^2 measured on enrollment
- willing to participate in the study
Exclusion criteria
- multiple pregnancy (carrying two or more fetuses)
- threatened abortion, persistent pervaginal bleeding, or cervical incompetence
- history of three or more consecutive abortions
- history of gestational diabetes, macrosomia, gestational hypertension, preeclampsia/eclampsia in a prior pregnancy
- chronic diseases, such as hypertension, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, pancreatic diseases, Crohn's disease, ulcerative colitis, diabetes mellitus, thyroid dysfunction, immunological diseases, malignancy or any other diseases which could impede compliance with the study protocol
- taking medications known to influence fetal growth, such as insulin, thyroid hormones, glucocorticoids
- known case of serious psychiatric or behavioral disorders, such as schizophrenia, bipolar disorder
- scored as moderate or worse on enrollment on any one of the subscales of the Depression, Anxiety and Stress Scales-21 (DASS-21)
- inability to read or write Bengali
- belonging to moderately or severely food insecure households as measured by the Household Food Insecurity Access Scale (HFIAS)
- having a plan to move or deliver outside the study area
- women practicing some form of vegetarianism
- women belonging to a household from which another woman is already enrolled in the study
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Badania usług zdrowotnych
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Intervention
In this arm, pregnant women, along with their influential family members such as mothers, mothers-in-law, and husbands, will receive monthly in-home, intensive nutrition counseling during the prenatal period.
|
|
|
Brak interwencji: Control
Pregnant women in this arm will receive standard antenatal care.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to IOM 2009 guidelines
Ramy czasowe: Pre-delivery
|
Pregnancy trimesters are defined as follows: 1st trimester (0 weeks - 13+6 weeks), 2nd trimester (14 completed weeks - 27+6 weeks), and 3rd trimester (28 completed weeks - childbirth).
Rate of weight gain between two time points (trimesters) will be calculated by subtracting the weight measured at the first time point from the weight measured at the second time point and dividing the derived value by the difference in weeks between the two time points.
|
Pre-delivery
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
total gestational weight gain (kg)
Ramy czasowe: pre-delivery
|
pre-delivery
|
|
|
rate of weight gain during the 2nd and 3rd trimester (kg/week)
Ramy czasowe: pre-delivery
|
pre-delivery
|
|
|
proportion of women with inadequate total GWG according to IOM criteria
Ramy czasowe: pre-delivery
|
pre-delivery
|
|
|
proportion of women with inadequate total GWG according to local criteria
Ramy czasowe: pre-delivery
|
pre-delivery
|
|
|
proportion of women with inadequate third trimester weight gain according to local criteria
Ramy czasowe: pre-delivery
|
pre-delivery
|
|
|
proportion of preterm births
Ramy czasowe: at delivery
|
childbirth before 37 completed weeks
|
at delivery
|
|
maternal mid-upper arm circumference (MUAC) (mm)
Ramy czasowe: baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum
|
baseline, 36 weeks of gestation, at delivery and 6 weeks post-partum
|
|
|
maternal weight (kg)
Ramy czasowe: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
|
baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
|
|
|
maternal body mass index (BMI) (kg/m^2)
Ramy czasowe: baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
|
weight and height (at baseline) will be combined to report BMI
|
baseline, 36 weeks of gestation, pre-delivery, at delivery and 6 weeks post-partum
|
|
infant weight (g)
Ramy czasowe: at birth (delivery) and after 4 weeks
|
at birth (delivery) and after 4 weeks
|
|
|
infant length (cm)
Ramy czasowe: at birth (delivery) and after 4 weeks
|
at birth (delivery) and after 4 weeks
|
|
|
infant head circumference (cm)
Ramy czasowe: at birth (delivery) and after 4 weeks
|
at birth (delivery) and after 4 weeks
|
|
|
proportion of low birth weight (< 2500 g) infants
Ramy czasowe: at birth (delivery)
|
at birth (delivery)
|
|
|
proportion of small for gestational age (<10th percentile) infants according to Intergrowth-21st standards
Ramy czasowe: at birth (delivery)
|
at birth (delivery)
|
|
|
proportion of women with pregnancy complications e.g. anemia, preeclampsia
Ramy czasowe: at delivery
|
at delivery
|
|
|
proportion of women with obstetric complications e.g. induction of labor, caesarean section
Ramy czasowe: at delivery
|
at delivery
|
|
|
newborn Apgar score
Ramy czasowe: at birth (delivery)
|
at birth (delivery)
|
|
|
proportion of infants developing morbidity
Ramy czasowe: 4 weeks after birth
|
4 weeks after birth
|
|
|
proportion of infant mortality
Ramy czasowe: 4 weeks after birth
|
4 weeks after birth
|
|
|
dietary diversity score according to the "Guidelines for Measuring Household and Individual Dietary Diversity"
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
score range: 0-9; higher scores indicate a better outcome
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
dietary diversity score according to the "Minimum Dietary Diversity for Women: A Guide to Measurement"
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
score range: 0-10; higher scores indicate a better outcome
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
proportion of women with inadequate dietary diversity accroding to the "Minimum Dietary Diversity for Women: A Guide to Measurement"
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
score range: 0-10; <5 indicates inadequate dietary diversity
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
energy consumption (kcal)
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
|
protein consumption (g)
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
|
proportion of women with symptoms of depression as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms.
Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
proportion of women with symptoms of anxiety as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms.
Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
proportion of women with symptoms of stress as measured by Depression, Anxiety, and Stress Scales-21 (DASS-21) scales
Ramy czasowe: baseline, 36 weeks of gestation and 6 weeks post-partum
|
DASS-21 is a validated, widely used, standardized self-report scale with 7 items in each subscale category of Depression, Anxiety, and Stress symptoms.
Responses are scored on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much/most of the time), with higher scores indicating higher levels of depression, anxiety or stress.
|
baseline, 36 weeks of gestation and 6 weeks post-partum
|
|
healthcare seeking and services utilization e.g. number of prenatal visits
Ramy czasowe: at delivery
|
at delivery
|
Współpracownicy i badacze
Współpracownicy
Śledczy
- Główny śledczy: S. M. Tafsir Hasan, MBBS, MS, Nutrition and Clinical Services Division, icddr,b
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- PR-19109
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Przyrost masy ciała w ciąży
-
Sansum Diabetes Research InstituteZakończonyCukrzyca typu 2 | Cukrzyca Mel Gestational - w ciążyStany Zjednoczone
-
Athabasca UniversityZakończonyCukrzyca Gestational Poprzednia ciążaKanada
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)RekrutacyjnyPrzyrost masy ciała w ciąży | Podwójne użycie papierosów i e-papierosów | Wynik Z-W-W-Wight-for-Gestational-AgeStany Zjednoczone
-
Rio de Janeiro State UniversityCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... i inni współpracownicyZawieszonyPowikłania ciąży | Otyłość, matka | Cukrzyca Mel Gestational - w ciążyBrazylia
-
Paul SzabolcsRekrutacyjnyPrzewlekła choroba ziarniniakowa | Zespół DiGeorge'a | Dysregulacja odporności | Pospolity zmienny niedobór odporności (CVID) | Syndrom Omenna | Niedobór liganda CD40 | Mendlowska podatność na chorobę mykobakteryjną | Pierwotne zaburzenie regulacji immunologicznej | STAT 1 Zysk Funkcji | STAT 3 Gain of Function i inne warunkiStany Zjednoczone
Badania kliniczne na In-home, intensive nutrition counseling
-
VA Eastern Colorado Health Care SystemUS Department of Veterans AffairsRekrutacyjnyMyśli samobójcze | Kwestia zdrowia psychicznego | Społeczne uwarunkowania zdrowiaStany Zjednoczone
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR); Unity Health Toronto; Mount Sinai... i inni współpracownicyZakończonyNie-anemiczny niedobór żelazaKanada